BioSpace News Archive

United Therapeutics Corporation announced the United States Patent and Trademark Office issued a new patent on July 21, 2020, relating to Tyvaso® Inhalation Solution. The new patent, U.S. Patent No.

Sciton Inc., a leading manufacturer of medical and aesthetic lasers and light source technologies, celebrates a record-breaking June coming off the most successful product launch in company history.

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, today announced the completion of enrollment in its controlled, Phase 2 trial of relacorilant combined with nab-paclitaxel (Abraxane ® ) in patients with metastatic, platinum-resistant ovarian cancer. “We achieved

Chairman and CEO Kenneth L. Londoner to provide an update on the commercial rollout of PURE EP(tm) System, clinical development of BioSig’s pharmaceutical subsidiary and conduct virtual one-on-one meetings with investors